Expressions of VEGF-C, D/VEGFR-3 in pancreatic cancer and their clinical significance
Wuyuan Zhou
Abstract
Wuyuan Zhou
Abstract
OBJECTIVE:To investigate the relationship between VEGF-C,VEGF-D,MLVD,MVD and lymph node metastasis in pancreatic cancer, and elucidate the mechanism and significance of the cancerous peripheral tissue lymphatic.METHODS: The expressions of VEGF-C,VEGF-D,MLVD,MVD were assayed by means of immunohistochemistry in 30 patients with pancreatic carcinoma. RESULTS: The positive rates of VEGF-C,VEGF-D were 73%(22/30), 57%(17/30) respectively in pancreatic cancer.The expressions of VEGF-C and VEGF-D in cancerous invasive edge were significantely higher than those in the center of cancerous tissues (P0.05). There was no correlation between the expressions of VEGF-C,VEGF-D and the site, differentiation, histology types. Ⅲ,Ⅳ stages of pancreatic cancer showed strong expressions of VEGF-C,VEGF-D than Ⅰ,Ⅱ stages of pancreatic (P0.01). The MVD,MLVD and positive lymph node in positive VEGF-C group were higher than in the negative group. The MLVD and positive lymph node in positive VEGF-D group were higher than those in the negative group.CONCLUSIONS: VEGF-C participates in the regulation of angiogenisis and lymphangiogenisis in pancreatic cancer, but VEGF-D only participates in the regulation of lymphangiogenisis. VEGF-C and VEGF-D induce lymphangiogenisis in pancreatic cancer and promote the tumor cell lymph metastasis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To investigate the relationship between VEGF-C,VEGF-D,MLVD,MVD and lymph node metastasis in pancreatic cancer, and elucidate the mechanism and significance of the cancerous peripheral tissue lymphatic.METHODS: The expressions of VEGF-C,VEGF-D,MLVD,MVD were assayed by means of immunohistochemistry in 30 patients with pancreatic carcinoma. RESULTS: The positive rates of VEGF-C,VEGF-D were 73%(22/30), 57%(17/30) respectively in pancreatic cancer.The expressions of VEGF-C and VEGF-D in cancerous invasive edge were significantely higher than those in the center of cancerous tissues (P0.05). There was no correlation between the expressions of VEGF-C,VEGF-D and the site, differentiation, histology types. Ⅲ,Ⅳ stages of pancreatic cancer showed strong expressions of VEGF-C,VEGF-D than Ⅰ,Ⅱ stages of pancreatic (P0.01). The MVD,MLVD and positive lymph node in positive VEGF-C group were higher than in the negative group. The MLVD and positive lymph node in positive VEGF-D group were higher than those in the negative group.CONCLUSIONS: VEGF-C participates in the regulation of angiogenisis and lymphangiogenisis in pancreatic cancer, but VEGF-D only participates in the regulation of lymphangiogenisis. VEGF-C and VEGF-D induce lymphangiogenisis in pancreatic cancer and promote the tumor cell lymph metastasis.
Key concepts: Pancreatic cancer, Lymph node, Medicine, VEGF receptors, Vascular endothelial growth factor C, Immunohistochemistry, Internal medicine, Lymph